Secteur Medicenna Therapeutics Corp.

Actions

MDNA

CA58490H1073

Recherche biotechnologique et médicale

Temps Différé Toronto S.E. 17:50:22 22/07/2026 Varia. 5j. Varia. 1 janv.
0,3500 CAD 0,00% Graphique intraday de Medicenna Therapeutics Corp. -4,11% -61,96%
Principaux concurrents
Varia. Varia. 5j. Variation 1 mois Variation 3 mois Varia. 1 janv. Varia. 1an Varia. 3ans Varia. 5ans Varia. 10ans Capi.($)
0,00%-4,11%-15,66%-40,68%-61,96%-56,79%-32,69%-87,76% - 22,92 M
-0,43%-1,26%+22,57%+27,75%+38,90%+52,13%+85,69%-24,52% - 55,57 Md
-0,24%+1,04%-4,72%+11,79%+5,80%+55,76%+58,36%+179,34%+5 742,84% 54,26 Md
-0,44%+0,16%+2,16%-15,16%-3,21%-17,32%-13,91%-67,21% - 23,35 Md
-1,05%-1,89%+9,26%-25,43%-38,10%+4,68%+426,58%+330,60%+874,12% 23,54 Md
+0,05%+1,68%+26,02%+10,03%+23,54%+38,71%-4,57%-70,53% - 20,32 Md
+3,16%+0,79%+15,43%+7,63%-5,72%+37,98%-29,06%-31,73%+66,46% 17,36 Md
+1,08%+3,77%+24,34%+3,30%+31,82%+36,92%+593,96% - - 15,59 Md
+0,43%-1,67%+23,49%+101,38%+178,50%+166,53%+299,61%+1 558,20%+608,58% 14,96 Md
-0,97%0,00%+8,18%+18,57%+26,74%+24,92%+179,29%+227,92%+539,98% 14,11 Md
+0,41%+0,00%+7,29%+3,99%-5,51%+75,58%+167,54%+505,23% - 12,61 Md
+4,55%+3,18%+12,96%-32,58%-12,48%-29,61%+165,86%+88,56% - 11,11 Md
+2,98%+0,84%+5,23%+25,75%+31,11%+120,98%+153,30%+176,78%+745,79% 11,01 Md
+1,44%-0,80%+4,69%-39,18%-14,52%-43,67%+651,26%+88,52%+109,09% 11,36 Md
+20,97%+27,49%+11,66%+23,87%+37,92%+512,07%+161,17%+34,81%+1 520,62% 10,5 Md
+0,02%0,00%+0,43%+15,71%+23,23%+50,33%+177,13% - - 9,83 Md
-0,03%-0,02%+137,10%+114,54%+80,20%+175,30%+352,45%+326,24% - 8,85 Md
+0,70%+4,00%+25,26%-25,78%+19,17%+22,92%+97,24%-14,16% - 8,92 Md
-2,20%-1,03%+0,69%+38,38%+208,35%+512,58%+584,85%-38,78%-13,11% 9,03 Md
-1,34%+11,06%+54,38%+37,09%+25,99%+36,76%+365,81%+338,86% - 8,84 Md
Moyenne +1,45%+0,24%+18,54%+13,05%+29,49%+88,84%+221,99%+195,58%+1 132,71% 17,06 Md
Moyenne pondérée par Capi. +0,86%+0,11%+15,56%+14,02%+26,42%+71,91%+182,61%+174,83%+2 259,53%
Médicaments bio-thérapeutiques
  1. Bourse
  2. Actions
  3. Action MDNA
  4. Secteur Medicenna Therapeutics Corp.